These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 14974885
21. Adjunctive corticosteroid therapy in pediatric severe sepsis: observations from the RESOLVE study. Zimmerman JJ, Williams MD. Pediatr Crit Care Med; 2011 Jan; 12(1):2-8. PubMed ID: 20228689 [Abstract] [Full Text] [Related]
22. [Two cases of severe sepsis successfully treated with activated protein C]. Aguirre Caballero A, Gutiérrez-Jodra Gamboa A, García Pérez Del Río JI, Lavilla Díaz M. Rev Esp Anestesiol Reanim; 2003 Dec; 50(10):539-43. PubMed ID: 14737782 [Abstract] [Full Text] [Related]
23. Adjunctive corticosteroid therapy in pediatric severe sepsis: many unsolved questions. Leclerc F, Botte A, Chêne G, Leteurtre S. Pediatr Crit Care Med; 2011 Jan; 12(1):101-2. PubMed ID: 21209569 [No Abstract] [Full Text] [Related]
24. Use of recombinant human activated protein C in treatment of severe sepsis in a pregnant patient with fully symptomatic ovarian hyperstimulation syndrome. Mikaszewska-Sokolewicz M, Mayzner-Zawadzka E. Med Sci Monit; 2005 Jun; 11(6):CS27-32. PubMed ID: 15917724 [Abstract] [Full Text] [Related]
25. Use of activated protein C in liver transplantation patients with septic shock. Rinaldi L, Marietta M, Mignini MA, Donno L, Busani S, Codeluppi M, Masetti M, Girardis M. Liver Transpl; 2008 Nov; 14(11):1598-602. PubMed ID: 18972572 [Abstract] [Full Text] [Related]
26. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Odetola FO, Gebremariam A, Freed GL. Pediatrics; 2007 Mar; 119(3):487-94. PubMed ID: 17332201 [Abstract] [Full Text] [Related]
27. Protein C -1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis. Walley KR, Russell JA. Crit Care Med; 2007 Jan; 35(1):12-7. PubMed ID: 17080006 [Abstract] [Full Text] [Related]
28. Candida colonization and candidemia in a pediatric intensive care unit. Singhi S, Rao DS, Chakrabarti A. Pediatr Crit Care Med; 2008 Jan; 9(1):91-5. PubMed ID: 18477920 [Abstract] [Full Text] [Related]
29. Replacement treatment with protein C in an 18-year-old man with meningococcal sepsis and purpura fulminans. Vaccarella G, Pelella R. Minerva Anestesiol; 2003 Sep; 69(9):691-3, 693-5. PubMed ID: 14564239 [Abstract] [Full Text] [Related]
30. Activated protein C for the treatment of severe sepsis. Houston G, Cuthbertson BH. Clin Microbiol Infect; 2009 Apr; 15(4):319-24. PubMed ID: 19416303 [Abstract] [Full Text] [Related]
31. Protein C concentrations correlate with organ dysfunction and predict outcome independent of the presence of sepsis. Brunkhorst F, Sakr Y, Hagel S, Reinhart K. Anesthesiology; 2007 Jul; 107(1):15-23. PubMed ID: 17585211 [Abstract] [Full Text] [Related]
32. [Adjuvant therapies for sepsis and shock: which are more effective?]. Groeneveld AB, Beishuizen A, Appelmelk BJ, Girbes AR. Ned Tijdschr Geneeskd; 2001 Sep 08; 145(36):1718-22. PubMed ID: 11572169 [Abstract] [Full Text] [Related]
33. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Balk RA. Dis Mon; 2004 Apr 08; 50(4):168-213. PubMed ID: 15133467 [Abstract] [Full Text] [Related]
36. Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsis. Yan SB, Dhainaut JF, Schwarz HP, Ehrlich HJ. Crit Care Med; 2004 Feb 08; 32(2):618; author reply 618-9. PubMed ID: 14758203 [No Abstract] [Full Text] [Related]
40. Subcutaneous protein C concentrate in the management of severe protein C deficiency--experience from 12 centres. Minford A, Behnisch W, Brons P, David M, Gomez Gomez N, Hertfelder HJ, Kruempel A, Kurnik K, Mathias M, Molines Honrubia A, Monagle P, Morgan M, Nowak-Göttl U, Olivieri M. Br J Haematol; 2014 Feb 08; 164(3):414-21. PubMed ID: 24422725 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]